References
- LewinsohnDMOfficial American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and childrenClin. Infect. Dis.201764 111 11510.1093/cid/ciw7785504475
- World Health Organization. Global Tuberculosis Report2016 142 (World Health Organization, 2016).
- SchlugerNWThe growing challenge of nontuberculous mycobacteriaChest201414652953010.1378/chest.14-0279
- GriffithDEAn official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseasesAm. J. Respir. Crit. Care Med.200717536741610.1164/rccm.200604-571ST
- Philley, J. V. et al. Treatment of non-tuberculous mycobacterial lung disease. Curr. Treat. Options Infect. Dis.8, 275–296 (2016).
- Koh, W.-J. Nontuberculous mycobacteria—overview. Microbiol. Spectr. 5, 1–24 (2017).
- Brown-Elliott, B. A. & Philley, J. V. Rapidly growing mycobacteria. Microbiol. Spectr. 5, 1–27 (2017).
- KangYAKohWJAntibiotic treatment for nontuberculous mycobacterial lung diseaseExpert Rev. Respir. Med.20161055756810.1586/17476348.2016.1165611
- van Ingen, J. Diagnosis of nontuberculous mycobacterial infections. Semin. Respir. Crit. Care Med. 34, 103–109 (2013).
- Jorgensen, J., Pfaller, M. & Carroll, K. in Manual of Clinical Microbiology 11th edn. (ASM: Washington, DC, 2015).
- TortoliEPecorariMFabioGMessinòMFabioACommercial DNA probes for mycobacteria incorrectly identify a number of less frequently encountered speciesJ. Clin. Microbiol.20104830731010.1128/JCM.01536-09
- TortoliESimonettiMTLaviniaFEvaluation of reformulated chemiluminescent DNA probe (AccuProbe) for culture identification of Mycobacterium kansasiiJ. Clin. Microbiol.19963428382840229416
- TortoliEMariottiniAMazzarelliGEvaluation of INNO-LiPA MYCOBACTERIAv2: improved reverse hybridization multiple DNA probe assay for mycobacterial identificationJ. Clin. Microbiol.2003414418442010.1128/JCM.41.9.4418-4420.2003193803
- SharmaKSharmaMBatraNSharmaADhillonMSDiagnostic potential of multi-targeted LAMP (Loop-mediated isothermal amplification) for osteoarticular tuberculosisJ. Orthop.2016352361365
- BhollaMEvaluation of Xpert(R) MTB/RIF and Ustar EasyNAT TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive studyBMC Infect. Dis.20161610.1186/s12879-016-1578-z4895953
- YamWCDiagnostic application of genotypic identification of mycobacteriaJ. Med Microbiol.20065552953610.1099/jmm.0.46298-0
- MatherCARiveraSFButler-WuSMComparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocolsJ. Clin. Microbiol.20145213013810.1128/JCM.01996-133911429
- van EckKMatrix-assisted laser desorption ionization-time of flight mass spectrometry fails to identify nontuberculous mycobacteria from primary cultures of respiratory samplesJ. Clin. Microbiol.2016541915191710.1128/JCM.00304-164922120
- LevesqueSA side by side comparison of bruker biotyper and VITEK MS: utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratoryPLoS One201510e014487810.1371/journal.pone.01448784689555
- KehrmannJPerformance of Vitek MS in identifying nontuberculous mycobacteria from MGIT liquid medium and Lowenstein–Jensen solid mediumDiagn. Microbiol Infect. Dis.201684434710.1016/j.diagmicrobio.2015.10.007
- DunneWMRapid inactivation of mycobacterium and nocardia species before identification using matrix-assisted laser desorption ionization–time of flight mass spectrometryJ. Clin. Microbiol.2014523654365910.1128/JCM.01728-144187772
- Rodriguez-SanchezBEvaluation of MALDI biotyper mycobacteria library v3.0 for identification of nontuberculous mycobacteriaJ. Clin. Microbiol.2016541144114710.1128/JCM.02760-154809906
- ChienJYYuCJHsuehPRIdentification of nontuberculous mycobacteria in MGIT by matrix-assisted laser desorption/ionization mass spectrometryFuture Microbiol.2016111025103310.2217/fmb.16.20
- MarekovicIEvaluation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in identification of nontuberculous mycobacteriaChemotherapy20166116717010.1159/000442517
- TottyHMillerEMorenoEDunneWMDeolPComparison of mechanical disruption techniques for rapid inactivation of mycobacterium and nocardia species before identification using matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometryJ. Clin. Microbiol.2016542626262710.1128/JCM.01096-165035402
- BalážováTThe influence of culture conditions on the identification of mycobacterium species by MALDI-TOF MS profilingFEMS Microbiol Lett.2014353778410.1111/1574-6968.12408
- MachenAKobayashiMConnellyMRWangYFWComparison of heat inactivation and cell disruption protocols for identification of mycobacteria from solid culture media by use of Vitek matrix-assisted laser desorption ionization–time of flight mass spectrometryJ. Clin. Microbiol.2013514226422910.1128/JCM.02612-133838084
- WilenCBMcMullenARBurnhamCAComparison of sample preparation methods, instrumentation platforms, and contemporary commercial databases for identification of clinically relevant mycobacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometryJ. Clin. Microbiol.2015532308231510.1128/JCM.00567-154473241
- GirardVIdentification of mycobacterium spp. and nocardia spp. from solid and liquid cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)Diagn. Microbiol Infect. Dis.20168627728310.1016/j.diagmicrobio.2016.07.027
- Brown-ElliottBANashKAWallaceRJJr.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteriaClin. Microbiol Rev.20122554558210.1128/CMR.05030-113416486
- BuckwalterSPEvaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of mycobacterium species, nocardia species, and other aerobic actinomycetesJ. Clin. Microbiol.20165437638410.1128/JCM.02128-154733196
- SchweickertBOccurrence and clinical relevance of Mycobacterium chimaera sp. nov., GermanyEmerg. Infect. Dis.2008141443144610.3201/eid1409.0710322603105
- VuorenmaaKBen SalahIBarlogisVChambostHDrancourtMMycobacterium colombiense and pseudotuberculous lymphadenopathyEmerg. Infect. Dis.20091561962010.3201/eid1504.0814362671429
- MurciaMITortoliEMenendezMCPalenqueEGarciaMJMycobacterium colombiense sp. nov., a novel member of the Mycobacterium avium complex and description of MAC-X as a new ITS genetic variantInt J. Syst. Evol. Microbiol.2006562049205410.1099/ijs.0.64190-0
- SalahIBCayrouCRaoultDDrancourtMMycobacterium marseillense sp. nov., Mycobacterium timonense sp. nov. and Mycobacterium bouchedurhonense sp. nov., members of the Mycobacterium avium complexInt J. Syst. Evol. Microbiol.2009592803280810.1099/ijs.0.010637-0
- McMullenARWallaceMAPincusDHWilkeyKBurnhamCADEvaluation of the Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry system for identification of clinically relevant filamentous fungiJ. Clin. Microbiol.2016542068207310.1128/JCM.00825-164963483
- RothANovel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleasesJ. Clin. Microbiol.2000381094110486348
- ThomsonRTolsonCHuygensFHargreavesMStrain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCRInt J. Med Microbiol.201430448448910.1016/j.ijmm.2014.02.004
- JagielskiTMethodological and clinical aspects of the molecular epidemiology of mycobacterium tuberculosis and other mycobacteriaClin. Microbiol Rev.20162923929010.1128/CMR.00055-154786889
- EckburgPBClinical and chest radiographic findings among persons with sputum culture positive for Mycobacterium gordonae: a review of 19 casesChest.20001179610210.1378/chest.117.1.96
- MazzarelliGEvaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter studyJ. Clin. Microbiol.2003411779178210.1128/JCM.41.4.1779-1782.2003153925
- CorbettEMycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiologyInt J. Tuberc. Lung Dis.19993501507
- TortoliESurvey of 150 strains belonging to the Mycobacterium terrae complex and description of Mycobacterium engbaekiisp. nov., Mycobacterium heraklionense sp. nov. and Mycobacterium longobardum sp. novInt J. Syst. Evol. Microbiol.20136340141110.1099/ijs.0.038737-0
- WolinskyEMycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-upClin. Infect. Dis.19952095496310.1093/clinids/20.4.954
- LuoLEvaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium abscessus subspecies according to whole-genome sequencingJ. Clin. Microbiol.2016542982298910.1128/JCM.01151-165121389
- LuoLCharacterization of Mycobacterium abscessus subtypes in Shanghai of China: drug sensitivity and bacterial epidemicity as well as clinical manifestationsMedicine201695e233810.1097/MD.00000000000023384998240
- ParkJChoJLeeCHHanSKYimJJProgression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massilienseClin. Infect. Dis.20176430130810.1093/cid/ciw723
- MalmAChudzikBPiersiakTGawronAGlass surface as potential in vitro substratum for Candida famata biofilmAnn. Agr. Env Med.201017115118
- CLSI Guideline M5820171st edWayne, PAClinical and Laboratory Standards Institute
- McNabbAAdieKRodriguesMBlackWAIsaac-RentonJDirect identification of mycobacteria in primary liquid detection media by partial sequencing of the 65-kilodalton heat shock protein geneJ. Clin. Microbiol.200644606610.1128/JCM.44.1.60-66.20061351931
- TortoliEMicrobiological features and clinical relevance of new species of the genus MycobacteriumClin. Microbiol Rev.20142772775210.1128/CMR.00035-144187642